This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Thomas Grunwald: Innovator in Viral Research
Introduction
Thomas Grunwald is a notable inventor based in Germany. He has made significant contributions to the field of viral research, particularly in relation to the respiratory syncytial virus (RSV). His work focuses on the development of nucleic acid molecules that can be utilized in vaccine production.
Latest Patents
Thomas Grunwald holds a patent titled "Rsv F-Protein And Its Use." This invention pertains to a nucleic acid molecule that encodes for the F-protein of RSV or a fragment thereof. The patent emphasizes the expression of codon-optimized variants of this nucleic acid molecule in a human cell environment. It also covers vectors and compositions that include these nucleic acid molecules, as well as their application in vaccines and polypeptides coded by the nucleic acid molecules.
Career Highlights
Throughout his career, Thomas Grunwald has worked with esteemed institutions, including Ruhr-Universität Bochum and Pevion Biotech AG. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Due to space constraints, the details of his collaborations will not be included.
Conclusion
Thomas Grunwald is a dedicated inventor whose work in viral research has the potential to impact vaccine development significantly. His innovative approach to understanding and utilizing nucleic acid molecules showcases his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile